Benefits and risks of therapeutic alternatives for macrolide resistant pneumonia in children
Although Mycoplasma pneumoniae pneumonia (MPP) has been generally susceptible to macrolides, the emergence of macrolide-resistant MPP (MRMP) has made its treatment challenging. MRMP rapidly spread after the 2000s, especially in East Asia. MRMP is more common in children and adolescents than in adult...
Saved in:
Main Author: | Hyeon-Jong Yang (Author) |
---|---|
Format: | Book |
Published: |
Korean Pediatric Society,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of resistance acquisition and treatment of macrolide-resistant pneumonia in children
by: Hyeon-Jong Yang, et al.
Published: (2017) -
Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant pneumonia
by: Eun-Ae Yang, et al.
Published: (2017) -
The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
by: Leng M, et al.
Published: (2024) -
Prevalence and clinical manifestations of macrolide resistant pneumonia in Korean children
by: Eun Lee, et al.
Published: (2017) -
Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant pneumonia
by: Young Ho Seo, et al.
Published: (2014)